Adverse Effects Impact Treatment Selection for VEGF-Targeted Oral TKIs in Metastatic RCC
Axitinib, cabozantinib, and lenvatinib are first-line treatment options.
Source: pharmacytimes.com
Dane Fritzsche News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dane Fritzsche. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dane Fritzsche Today - Breaking & Trending Today